X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24100) 24100
Publication (1552) 1552
Book Review (471) 471
Newsletter (187) 187
Newspaper Article (102) 102
Magazine Article (83) 83
Book Chapter (73) 73
Conference Proceeding (35) 35
Book / eBook (12) 12
Trade Publication Article (8) 8
Dissertation (5) 5
Web Resource (5) 5
Data Set (3) 3
Government Document (3) 3
Paper (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15773) 15773
female (9532) 9532
index medicus (8158) 8158
male (7673) 7673
animals (6286) 6286
adult (4781) 4781
middle aged (4327) 4327
pharmacology & pharmacy (4173) 4173
acetates - therapeutic use (2939) 2939
aged (2636) 2636
rats (2367) 2367
treatment outcome (2344) 2344
mice (2321) 2321
oncology (2118) 2118
acetates (1813) 1813
medroxyprogesterone acetate (1721) 1721
analysis (1692) 1692
obstetrics & gynecology (1649) 1649
glatiramer acetate (1640) 1640
adolescent (1638) 1638
double-blind (1632) 1632
cancer (1537) 1537
care and treatment (1501) 1501
tetradecanoylphorbol acetate - pharmacology (1348) 1348
dose-response relationship, drug (1341) 1341
time factors (1332) 1332
acetic acid (1314) 1314
clinical neurology (1293) 1293
research (1265) 1265
health aspects (1230) 1230
multiple sclerosis (1197) 1197
therapy (1136) 1136
double-blind method (1116) 1116
neurosciences (1102) 1102
acetate (1086) 1086
drug therapy, combination (1081) 1081
biochemistry & molecular biology (1012) 1012
drug therapy (1004) 1004
acetates - pharmacology (986) 986
child (979) 979
endocrinology & metabolism (971) 971
immunology (953) 953
prostate cancer (951) 951
quinolines - therapeutic use (942) 942
medicine & public health (933) 933
medroxyprogesterone acetate - therapeutic use (919) 919
medicine, general & internal (893) 893
toxicology (893) 893
amines (889) 889
inflammation (870) 870
women (869) 869
expression (867) 867
androgen antagonists - therapeutic use (866) 866
prospective studies (857) 857
cyclohexanecarboxylic acids (856) 856
clinical trials as topic (830) 830
pregnancy (829) 829
antineoplastic agents - therapeutic use (822) 822
breast neoplasms - drug therapy (821) 821
antineoplastic agents, hormonal - therapeutic use (807) 807
aged, 80 and over (798) 798
disease models, animal (795) 795
administration, oral (792) 792
megestrol-acetate (787) 787
urology & nephrology (785) 785
peptides - therapeutic use (782) 782
postmenopausal women (779) 779
article (774) 774
gamma-aminobutyric acid (767) 767
chemistry, medicinal (755) 755
abiraterone acetate (747) 747
multiple sclerosis - drug therapy (741) 741
prostatic neoplasms - drug therapy (738) 738
in-vitro (724) 724
chemotherapy (706) 706
physiological aspects (693) 693
retrospective studies (682) 682
acetates - administration & dosage (681) 681
apoptosis (672) 672
drugs (671) 671
research article (668) 668
rats, sprague-dawley (666) 666
estrogen (656) 656
follow-up studies (648) 648
inhibition (648) 648
proteins (646) 646
risk factors (633) 633
young adult (628) 628
medicine (626) 626
randomized controlled trials as topic (626) 626
ethyl acetate (625) 625
asthma - drug therapy (614) 614
metabolism (606) 606
cells (598) 598
immunosuppressive agents - therapeutic use (593) 593
surgery (591) 591
antineoplastic combined chemotherapy protocols - therapeutic use (589) 589
cell biology (587) 587
placebo-controlled trial (584) 584
montelukast (583) 583
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22872) 22872
German (442) 442
French (285) 285
Japanese (267) 267
Spanish (183) 183
Russian (152) 152
Italian (93) 93
Chinese (66) 66
Polish (61) 61
Czech (28) 28
Portuguese (21) 21
Hungarian (17) 17
Dutch (12) 12
Bulgarian (11) 11
Finnish (10) 10
Danish (9) 9
Swedish (9) 9
Romanian (8) 8
Hebrew (5) 5
Serbian (4) 4
Croatian (3) 3
Norwegian (3) 3
Ukrainian (3) 3
Korean (2) 2
Slovak (2) 2
Indonesian (1) 1
Persian (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Advanced Pharmaceutical Technology and Research, ISSN 2231-4040, 01/2011, Volume 2, Issue 1, pp. 3 - 8
Cymbopogon citratus, Stapf (Lemon grass) is a widely used herb in tropical countries, especially in Southeast Asia. The essential oil of the plant is used in... 
phytoconstituents | Cymbopogon citratus | essential oil | flavonoids | Citronellal | Geranyl acetate | Essential oils | Esters | Alcohols | Fungi | Antioxidants | Leaves | Terpinolene | Aromatherapy | Drug dosages | Herbs | Free radicals | Antiinflammatory agents | Kaempferol | Inflammation | Grasses | Phenolic compounds | Chromatography | Flavonoids | Quercetin | Oils & fats | Terpenes | Acetic acid | Citral | Review
Journal Article
Journal Article
Clinical Obstetrics and Gynecology, ISSN 0009-9201, 03/2016, Volume 59, Issue 1, pp. 30 - 52
Fibroids are the most common tumor of the female reproductive tract, but approved medical treatments are limited. Patients demand uterine-sparing treatments... 
Leiomyoma | Medical therapy | Fibroids | Medical treatment | medical treatment | HYSTERECTOMY RATES | PROGESTERONE-RECEPTOR MODULATOR | fibroids | ULIPRISTAL ACETATE | medical therapy | PREMENOPAUSAL WOMEN | LEUPROLIDE ACETATE | OBSTETRICS & GYNECOLOGY | SHORT-TERM TREATMENT | DEPOT-MEDROXYPROGESTERONE ACETATE | POSTMENOPAUSAL WOMEN | HORMONE AGONIST | leiomyoma | SYMPTOMATIC UTERINE LEIOMYOMA | Estradiol - analogs & derivatives | Contraceptive Agents, Female - therapeutic use | Humans | Estrenes - therapeutic use | Oximes - therapeutic use | Receptors, Progesterone - antagonists & inhibitors | Intrauterine Devices, Medicated | Selective Estrogen Receptor Modulators - therapeutic use | Estrogen Receptor Antagonists - therapeutic use | Androgens - therapeutic use | Female | Neoadjuvant Therapy | Curcumin | Aromatase Inhibitors - therapeutic use | Drugs, Chinese Herbal - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Uterine Neoplasms - prevention & control | Estradiol - therapeutic use | Norpregnadienes - therapeutic use | Medroxyprogesterone Acetate - therapeutic use | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Evidence-Based Medicine | Uterine Myomectomy | Vitamins - therapeutic use | Leiomyoma - prevention & control | Contraceptives, Oral, Combined - therapeutic use | Tea | Leiomyoma - drug therapy | Uterine Neoplasms - drug therapy | Levonorgestrel - therapeutic use | Hormone Antagonists - therapeutic use | Vitamin D - therapeutic use | Delayed-Action Preparations | Plant Extracts - therapeutic use | Mifepristone - therapeutic use
Journal Article
1996, Progress in basic and clinical pharmacology, ISBN 3805560559, Volume 10, xiv, 312
Book
Best Practice & Research: Clinical Obstetrics & Gynaecology, ISSN 1521-6934, 2015, Volume 34, pp. 85 - 103
Uterine leiomyomas, or fibroids, are the most common benign tumor in reproductive aged women. Affected women may remain asymptomatic or may report symptoms... 
Obstetrics and Gynecology | uterine leiomyomas | medical management | abnormal uterine bleeding | fibroids | VITAMIN-D | PROGESTERONE-RECEPTOR MODULATOR | ULIPRISTAL ACETATE | LOW-DOSE MIFEPRISTONE | PREMENOPAUSAL WOMEN | OBSTETRICS & GYNECOLOGY | TRANEXAMIC ACID | AROMATASE INHIBITOR | GENE-EXPRESSION | GROWTH-FACTOR | HORMONE ANALOG | Antifibrinolytic Agents - therapeutic use | Contraceptive Agents, Female - therapeutic use | Contraceptives, Oral, Synthetic - therapeutic use | Humans | Contraceptive Agents, Female - administration & dosage | Dopamine Agonists - therapeutic use | Estrenes - therapeutic use | Oximes - therapeutic use | Intrauterine Devices, Medicated | Patient Care Planning | Selective Estrogen Receptor Modulators - therapeutic use | Cholecalciferol - therapeutic use | Female | Gestrinone - therapeutic use | Aromatase Inhibitors - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Danazol - therapeutic use | Contraceptives, Oral, Hormonal - therapeutic use | Somatostatin - analogs & derivatives | Norpregnadienes - therapeutic use | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Tranexamic Acid - therapeutic use | Vitamins - therapeutic use | Ergolines - therapeutic use | Estrogen Antagonists - therapeutic use | Levonorgestrel - administration & dosage | Leiomyoma - drug therapy | Uterine Neoplasms - drug therapy | Mifepristone - therapeutic use | Fluocinolone acetonide | Pituitary hormones | Progesterone
Journal Article
European Urology, ISSN 0302-2838, 2011, Volume 61, Issue 5, pp. 950 - 960
Abstract Context Improved understanding of mechanisms underlying metastatic castration-resistant prostate cancer (mCRPC) progression has led to the recognition... 
Urology | Molecular targets | Chemotherapy | Immunotherapy | Androgen pathway inhibitors | Biologic agents | Androgen receptor | Prostate cancer | Skeletal-related events | ADVANCED SOLID TUMORS | DOCETAXEL | PATHWAY ACTIVATION | MITOXANTRONE PLUS PREDNISONE | INHIBITION | RANDOMIZED PHASE-II | CLINICAL-TRIALS | UROLOGY & NEPHROLOGY | END-POINTS | HIGH-DOSE CALCITRIOL | Receptors, Vascular Endothelial Growth Factor | Anilides - therapeutic use | Phenylthiohydantoin - therapeutic use | Humans | Ipilimumab | Recombinant Fusion Proteins - therapeutic use | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Thiazoles - therapeutic use | Abiraterone Acetate | Quinolones | Antibodies, Monoclonal, Humanized | Taxoids - therapeutic use | Cancer Vaccines - therapeutic use | Clinical Trials, Phase III as Topic | Bone Neoplasms - drug therapy | Clusterin - therapeutic use | Prostatic Neoplasms - drug therapy | Carcinoma - secondary | Pyridines - therapeutic use | Carcinoma - drug therapy | Dasatinib | Prostatic Neoplasms - pathology | Prostatic Neoplasms - surgery | Carcinoma - surgery | Treatment Outcome | Vaccines, Synthetic - therapeutic use | Tissue Extracts - therapeutic use | Denosumab | Radium - therapeutic use | Phenylthiohydantoin - analogs & derivatives | Orchiectomy | Pyrimidines - therapeutic use | Androstadienes - therapeutic use | Quinolines - therapeutic use | Medical colleges | Hospitals | Development and progression | Metastasis | Tubulins | Cancer | Landscape | Conferences | Immunoregulation | Clinical trials | Data processing | Oncology | Src protein | Clusterin | Metastases | Angiogenesis | Signal transduction | Androgens | Antagonism | Databases | Reviews | Tubulin | Acetic acid
Journal Article